Gotham Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
35,629
+30,829
| +642% | +$1.51M | 0.01% | 969 |
|
|
2025
Q1 | $245K | Buy |
+4,800
| New | +$245K | ﹤0.01% | 1425 |
|
|
2024
Q2 | – | Sell |
-7,527
| Closed | -$219K | – | 1481 |
|
|
2024
Q1 | $219K | Buy |
+7,527
| New | +$219K | ﹤0.01% | 1273 |
|
|
2023
Q3 | – | Sell |
-6,781
| Closed | -$276K | – | 1399 |
|
|
2023
Q2 | $276K | Sell |
6,781
-5,536
| -45% | -$225K | 0.01% | 1145 |
|
|
2023
Q1 | $597K | Buy |
12,317
+5,512
| +81% | +$267K | 0.01% | 893 |
|
|
2022
Q4 | $260K | Sell |
6,805
-250
| -4% | -$9.54K | 0.01% | 1071 |
|
|
2022
Q3 | $354K | Buy |
7,055
+456
| +7% | +$22.9K | 0.01% | 938 |
|
|
2022
Q2 | $264K | Buy |
+6,599
| New | +$264K | 0.01% | 971 |
|
|
2021
Q3 | – | Sell |
-4,785
| Closed | -$202K | – | 1101 |
|
|
2021
Q2 | $202K | Hold |
4,785
| – | – | 0.01% | 951 |
|
|
2021
Q1 | $227K | Sell |
4,785
-1
| -0% | -$47 | 0.01% | 919 |
|
|
2020
Q4 | $292K | Sell |
4,786
-333
| -7% | -$20.3K | 0.01% | 841 |
|
|
2020
Q3 | $239K | Hold |
5,119
| – | – | 0.01% | 890 |
|
|
2020
Q2 | $260K | Sell |
5,119
-51
| -1% | -$2.59K | 0.01% | 894 |
|
|
2020
Q1 | $231K | Buy |
5,170
+37
| +0.7% | +$1.65K | 0.01% | 904 |
|
|
2019
Q4 | $247K | Buy |
+5,133
| New | +$247K | ﹤0.01% | 994 |
|
|
2019
Q3 | – | Sell |
-5,133
| Closed | -$231K | – | 1194 |
|
|
2019
Q2 | $231K | Buy |
+5,133
| New | +$231K | ﹤0.01% | 1026 |
|
|
2019
Q1 | – | Sell |
-11,079
| Closed | -$380K | – | 1222 |
|
|
2018
Q4 | $380K | Sell |
11,079
-1,761
| -14% | -$60.4K | 0.01% | 816 |
|
|
2018
Q3 | $603K | Buy |
12,840
+689
| +6% | +$32.4K | 0.01% | 702 |
|
|
2018
Q2 | $410K | Buy |
+12,151
| New | +$410K | 0.01% | 729 |
|
|
2017
Q4 | – | Sell |
-19,796
| Closed | -$396K | – | 1038 |
|
|
2017
Q3 | $396K | Buy |
+19,796
| New | +$396K | 0.01% | 744 |
|